Accès gratuit
Med Sci (Paris)
Volume 27, Numéro 3, Mars 2011
Page(s) 285 - 288
Section M/S revues
Publié en ligne 30 mars 2011
  1. LazennecG, JorgensenC. Concise review: adult multipotent stromal cells and cancer: risk or benefit?. Stem Cells 2008 ; 26 : 1387-1394. [CrossRef] [PubMed] [Google Scholar]
  2. WangH, CaoF, DeA, et al. Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells 2009 ; 27 : 1548-1558. [CrossRef] [PubMed] [Google Scholar]
  3. LoebingerMR, KyrtatosPG, TurmaineM, et al. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 2009 ; 69 : 8862-8867. [CrossRef] [PubMed] [Google Scholar]
  4. HoIA, ChanKY, NgWH, et al. Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma. Stem Cells 2009 ; 27 : 1366-1375. [CrossRef] [PubMed] [Google Scholar]
  5. GutovaM, NajbauerJ, FrankRT, et al. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors. Stem Cells 2008 ; 26 : 1406-1413. [CrossRef] [PubMed] [Google Scholar]
  6. DwyerRM, Potter-BeirneSM, HarringtonKA, et al. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res 2007 ; 13 : 5020-5027. [CrossRef] [PubMed] [Google Scholar]
  7. KimDS, KimJH, LeeJK, et al. Overexpression of CXC chemokine receptors is required for the superior glioma-tracking property of umbilical cord blood-derived mesenchymal stem cells. Stem Cells Dev 2009 ; 18 : 511-519. [CrossRef] [PubMed] [Google Scholar]
  8. BirnbaumT, RoiderJ, SchankinCJ, et al. Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. Neurooncol 2007 ; 83 : 241-247. [CrossRef] [Google Scholar]
  9. FengB, ChenL.. Review of mesenchymal stem cells and tumors: executioner or coconspirator?. Cancer Biother Radiopharm 2009 ; 24 : 717-721. [CrossRef] [PubMed] [Google Scholar]
  10. SpaethE, KloppA, DembinskiJ, et al. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther 2008 ; 15 : 730-738. [CrossRef] [PubMed] [Google Scholar]
  11. KiddS, SpaethE, DembinskiJL, et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 2009 ; 27 : 2614-2623. [CrossRef] [PubMed] [Google Scholar]
  12. KarnoubAE, DashAB, VoAP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007 ; 449 : 557-563. [CrossRef] [PubMed] [Google Scholar]
  13. MakinoshimaH, DezawaM.. Pancreatic cancer cells activate CCL5 expression in mesenchymal stromal cells through the insulin-like growth factor-I pathway. FEBS Lett 2009 ; 583 : 3697-3703. [CrossRef] [PubMed] [Google Scholar]
  14. CoffeltSB, MariniFC, WatsonK, et al. The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proc Natl Acad Sci USA 2009 ; 106 : 3806-3811. [CrossRef] [Google Scholar]
  15. SpaethEL, DembinskiJL, SasserAK, et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 2009 ; 4 : e4992. [CrossRef] [PubMed] [Google Scholar]
  16. SasserAK, SullivanNJ, StudebakerAW, et al. Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer. Faseb J 2007 ; 21 : 3763-3770. [CrossRef] [PubMed] [Google Scholar]
  17. MolloyAP, MartinFT, DwyerRM, et al. Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells. Int J Cancer 2009 ; 124 : 326-332. [CrossRef] [PubMed] [Google Scholar]
  18. DjouadF, PlenceP, BonyC, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003 ; 102 : 3837-3844. [CrossRef] [PubMed] [Google Scholar]
  19. ZhuY, SunZ, HanQ, et al. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia 2009 ; 23 : 925-933. [CrossRef] [PubMed] [Google Scholar]
  20. MartinFT, DwyerRM, KellyJ, et al. Potential role of mesenchymal stem cells (CSMs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat 2010 ; 124 : 317-326. [CrossRef] [PubMed] [Google Scholar]
  21. OrimoA, GuptaPB, SgroiDC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005 ; 121 : 335-348. [CrossRef] [PubMed] [Google Scholar]
  22. MishraPJ, MishraPJ, HumeniukR, et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008 ; 68 : 4331-4339. [CrossRef] [PubMed] [Google Scholar]
  23. VilaltaM, DeganoIR, BagoJ, et al. Human adipose tissue-derived mesenchymal stromal cells as vehicles for tumor bystander effect: a model based on bioluminescence imaging. Gene Ther 2009 ; 16 : 547-557. [CrossRef] [PubMed] [Google Scholar]
  24. KucerovaL, AltanerovaV, MatuskovaM, et al. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 2007 ; 67 : 6304-6313. [CrossRef] [PubMed] [Google Scholar]
  25. LoebingerMR, EddaoudiA, DaviesD, JanesSM. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res 2009 ; 69 : 4134-4142. [CrossRef] [PubMed] [Google Scholar]
  26. FritzV, NoelD, BouquetC, et al. Antitumoral activity and osteogenic potential of hATF-expressing mesenchymal stem cells in a murine model of osteolytic tumor. Stem Cells 2008 ; 26 : 2981-2990. [CrossRef] [PubMed] [Google Scholar]
  27. ChenXC, WangR, ZhaoX, et al. Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered CSMs. Carcinogenesis 2006 ; 27 : 2434-2441. [CrossRef] [PubMed] [Google Scholar]
  28. LiX, LuY, HuangW, et al. In vitro effect of adenovirus-mediated human Gamma Interferon gene transfer into human mesenchymal stem cells for chronic myelogenous leukemia. Hematol Oncol 2006 ; 24 : 151-158. [CrossRef] [PubMed] [Google Scholar]
  29. KomarovaS, KawakamiY, Stoff-KhaliliMA, et al. Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol Cancer Ther 2006 ; 5 : 755-766. [CrossRef] [PubMed] [Google Scholar]
  30. WalkleyCR, OlsenGH, DworkinS, et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell 2007 ; 129 : 1097-1110. [CrossRef] [PubMed] [Google Scholar]
  31. RaaijmakersMH, MukherjeeS, GuoS, et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 2010 ; 464 : 852-857. [CrossRef] [PubMed] [Google Scholar]
  32. MenendezP, CatalinaP, RodriguezR, et al. Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene. Exp Med 2009 ; 206 : 3131-3141. [CrossRef] [Google Scholar]
  33. RogerM, ClavreulA, MeneiP. Cellules stromales mésenchymateuses : vecteurs cellulaires de nanoparticules au sein de tumeurs cérébrales. Med Sci (Paris) 2011 ; 27 : 234-236. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.